IRIS
GRASSADONIA, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.301
EU - Europa 3.205
AS - Asia 2.762
SA - Sud America 408
AF - Africa 42
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.215
SG - Singapore 1.247
CN - Cina 801
IT - Italia 659
IE - Irlanda 540
SE - Svezia 378
BR - Brasile 359
UA - Ucraina 343
FR - Francia 337
GB - Regno Unito 303
DE - Germania 255
TR - Turchia 229
VN - Vietnam 189
IN - India 111
FI - Finlandia 89
RU - Federazione Russa 80
CA - Canada 50
PL - Polonia 46
HK - Hong Kong 41
BE - Belgio 34
JP - Giappone 30
CZ - Repubblica Ceca 29
MX - Messico 26
NL - Olanda 23
AT - Austria 21
ES - Italia 19
ZA - Sudafrica 19
AU - Australia 18
KR - Corea 18
AR - Argentina 17
BD - Bangladesh 17
IQ - Iraq 17
LT - Lituania 16
EG - Egitto 9
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
EC - Ecuador 7
NZ - Nuova Zelanda 6
PK - Pakistan 6
RO - Romania 6
UZ - Uzbekistan 6
VE - Venezuela 6
CH - Svizzera 5
EU - Europa 5
MA - Marocco 5
CO - Colombia 4
ID - Indonesia 4
IL - Israele 4
JO - Giordania 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
DZ - Algeria 3
HN - Honduras 3
IR - Iran 3
KW - Kuwait 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MT - Malta 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
Totale 10.747
Salva come PNG Salva come JPEG
Città #
Singapore 937
Chandler 657
Dublin 528
Jacksonville 436
Ashburn 291
Dallas 260
Beijing 234
Princeton 203
Southend 166
Los Angeles 147
The Dalles 144
Izmir 132
Nanjing 128
Santa Clara 119
Chieti 93
Pescara 91
New York 89
Ann Arbor 84
Dearborn 84
Wilmington 84
Altamura 83
Munich 76
Boardman 67
Cambridge 62
Tongling 60
Ho Chi Minh City 57
Buffalo 44
Dong Ket 40
Redondo Beach 39
São Paulo 38
Hong Kong 37
Nanchang 37
Brussels 32
Nuremberg 32
Rome 31
Hanoi 29
Woodbridge 28
Hefei 27
Tokyo 27
Washington 27
Denver 26
Brooklyn 25
London 24
Brno 23
Montreal 23
Atlanta 22
Hebei 22
Chicago 21
Kunming 21
Milan 21
Shenyang 21
Warsaw 21
Tianjin 20
Norwalk 19
Stockholm 19
Frankfurt am Main 18
Houston 18
Jiaxing 18
Kraków 18
Boston 17
Amsterdam 16
Council Bluffs 16
Johannesburg 15
Seoul 15
Falls Church 14
Helsinki 14
Poplar 14
Turku 14
Changsha 13
Orem 13
Phoenix 13
Chennai 12
Lappeenranta 12
Ancona 11
Grevenbroich 11
Hyderabad 11
Rio de Janeiro 11
Vienna 11
Manchester 10
Seattle 10
Hangzhou 9
Melbourne 9
Augusta 8
Belo Horizonte 8
Guangzhou 8
Guarulhos 8
Mexico City 8
Bristol 7
Cairo 7
Campina Grande 7
Campinas 7
Changchun 7
Charlotte 7
City of London 7
Da Nang 7
Oklahoma City 7
San Francisco 7
Santa Fe 7
Tappahannock 7
Toronto 7
Totale 6.602
Salva come PNG Salva come JPEG
Nome #
90K (Mac-2 BP) and galectins in tumor progression and metastasis. 159
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 149
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 147
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. 145
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 145
The Role of the Environment and Type of Exercise on Acute Adrenal Modulation and Perceived Distress of Breast Cancer Survivors Practising Light-Intensity Physical Exercise 144
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 138
Gli analoghi sintetici delle glicoamine come potenziali nuovi farmaci nella prevenzione delle metastasi 135
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. 134
New Targets for Therapy in Pancreatic Cancer 134
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 132
Exosomes as pleiotropic players in pancreatic cancer 132
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 130
Occupational allergy: is there a role for nanoparticles? 129
Analisi dello stato mutazionale di K-RAS: un nuovo strumento per la selezione dei pazienti candidati a terapia con anticorpi anti-EGFR 127
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression 127
Glicomimetici quali potenziali nuovi farmaci per la prevenzione delle metastasi. 126
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients. 125
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors 123
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 123
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 123
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 122
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 122
A novel serum test using interferon for early detection of tumor reccurrence in cancer patients after radical surgery. 121
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 121
Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells 120
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 120
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 119
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein. 118
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 117
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice. 116
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer 116
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 115
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 113
The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. 112
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 110
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial. 109
TGF-β-1 increases 90K tumor associated antigen gene expression by increasing upstream regulatory factor binding to the minimal promoter. 108
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 108
BIOLOGICAL INDICATORS OF PROGNOSIS IN HUMAN CANCER: AN EMERGING ROLE FOR LECTIN GALACTOSIDE-BINDING SOLUBLE 3-BINDING PROTEIN (LGALS3BP) 108
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag 107
Principali effetti collaterali delle terapie mediche 107
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 104
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 104
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey 103
Tumor-derived microvesicles: The metastasomes. 102
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 100
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 100
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study 99
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions. 98
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 98
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 98
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage 97
La stimolazione dinamica con IFN-α per la diagnosi precoce di ripresa di malattia in pazienti NED 96
Circadian timing of chemotherapeutic agents:a phase II study of 5-fluoro-2-deoxyuridine in gastrointestinal cancer and renal cell carcinoma 96
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 95
Regolazione, funzione ed espressione genica dell’antigene tumore-associato 90K/AC-2 BP 94
Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer 91
Oral etoposide and platinum derivates in the treatment of metastatic Merkel cell carcinoma: report of three cases 91
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? 91
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies 90
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: A systematic review 90
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 90
Prognostic value of gender and primary tumor location in metastatic colon cancer 89
Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 88
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly 88
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer 88
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 88
Alectinib induced regression of renal and hepatic cysts caused by crizotinib 87
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 86
Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function 85
Relationships between daily physical activity combinations and psychophysical health status of Italian breast cancer survivors 85
Possible role of thymidylate synthase level in hunan colorectal carcinoma: a new prognostic factor? 84
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. 84
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 84
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial 83
Pretreatment neutrophil-lymphocyte ratio (NLR) predicted overall survival (OS) for metastatic melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) patients who received monotherapy with immune checkpoint inhibitor as ipilimumab, nivolumab and pembrolizumab 83
Prognostic value of a novel interferon-inducible 90K tumor antigen 81
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 80
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 80
Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study 79
Effect of taxanes following anthracyclines on pathologic complete response (pCR) in patients with triple-negative breast cancer (TNBC) receiving primary systemic therapy (PST). 79
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 78
Infusione cronomodulata di farmaci in oncologia 77
Impact of Body Mass Index (BMI) on outcome of metastatic breast cancer (MBC) patients (pts) treated with Eribulin in a real-world population: a multicenter retrospective study 77
Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression 76
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 76
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study. 75
FPSE-HPLC-DAD metod for the quantification of anticancer drugs in human whole blood, plasma and urine 75
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 75
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting 74
Flexibility and Strength Effects of Adapted Nordic Walking and Myofascial Exercises Practice in Breast Cancer Survivors and Analysis of Differences 73
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 73
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer 71
Current challenges in HER2-positive breast cancer 71
The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects 65
Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review 65
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 65
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 64
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting 63
Totale 10.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.241
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 114 18 19 41 61 40 63
2021/2022557 19 15 5 118 34 32 15 46 33 15 62 163
2022/20231.842 143 236 160 191 190 329 98 155 210 16 70 44
2023/20241.029 86 31 66 44 64 329 173 30 41 33 25 107
2024/20252.361 137 390 324 109 61 118 116 125 223 176 257 325
2025/20262.380 400 199 498 553 543 187 0 0 0 0 0 0
Totale 11.263